Cargando…

Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models

Neuropathic pain (NP) treatment remains a challenge because the pathomechanism is not yet fully understood. Because of low treatment efficacy, there is an important unmet need in neuropathic pain patients, and the development of a more effective pharmacotherapy is urgently required. Neuroinflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Cheng, He, Menglin, Chen, Meijuan, Xu, Qian, Li, Sha, Cui, Yaomei, Qiu, Xizi, Tian, Weiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956562/
https://www.ncbi.nlm.nih.gov/pubmed/34757554
http://dx.doi.org/10.1007/s10753-021-01593-x
_version_ 1784676593106419712
author Hu, Cheng
He, Menglin
Chen, Meijuan
Xu, Qian
Li, Sha
Cui, Yaomei
Qiu, Xizi
Tian, Weiqian
author_facet Hu, Cheng
He, Menglin
Chen, Meijuan
Xu, Qian
Li, Sha
Cui, Yaomei
Qiu, Xizi
Tian, Weiqian
author_sort Hu, Cheng
collection PubMed
description Neuropathic pain (NP) treatment remains a challenge because the pathomechanism is not yet fully understood. Because of low treatment efficacy, there is an important unmet need in neuropathic pain patients, and the development of a more effective pharmacotherapy is urgently required. Neuroinflammation induced by oxidative stress-mediated activation of nuclear factor-kappa B (NF-κB) plays an important role in NP. In this study, we aimed to investigate the protective properties of tetrahydropalmatine (THP) on a spared nerve injury (SNI) model of neuropathic pain in mice in in vivo and also in in vitro experiments. THP decreased mechanical hyperalgesia and cold allodynia compared with the SNI group. A microarray was applied to analyze differentially expressed of mRNA among different groups, and THP noticeably changed the expression of MAPK-related proteins compared with the SNI groups. H&E staining showed that the THP changed the inflammation after the spared nerve injury, with decreased NO expression in the THP group as compared to the SNI group. In addition, SNI-induced pain was reversed by intraperitoneal administration of THP, and further results indicated that THP suppressed inducible nitric oxide synthase (iNOS, pro-nociceptive mediators), phosphorylated MAPKs, and p65 in the dorsal root ganglions and sciatic nerve, while the serum levels of the pro-inflammatory cytokines IL-1β were significantly higher in the SNI group as compared to the THP group. To identify the molecular mechanism of the antineuropathic activity of THP, sodium nitroprusside (SNP)-induced neuro-2a (N2a) cells, LPS-induced BV2 cells, and LTA-induced astrocytes were further investigated in signaling pathways. In vitro experiments indicated that THP suppressed the expression of IL-1β, iNOS, phosphorylated MAPKs, and p65, which were assayed using western blotting, and immunofluorescence.
format Online
Article
Text
id pubmed-8956562
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-89565622022-04-07 Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models Hu, Cheng He, Menglin Chen, Meijuan Xu, Qian Li, Sha Cui, Yaomei Qiu, Xizi Tian, Weiqian Inflammation Original Article Neuropathic pain (NP) treatment remains a challenge because the pathomechanism is not yet fully understood. Because of low treatment efficacy, there is an important unmet need in neuropathic pain patients, and the development of a more effective pharmacotherapy is urgently required. Neuroinflammation induced by oxidative stress-mediated activation of nuclear factor-kappa B (NF-κB) plays an important role in NP. In this study, we aimed to investigate the protective properties of tetrahydropalmatine (THP) on a spared nerve injury (SNI) model of neuropathic pain in mice in in vivo and also in in vitro experiments. THP decreased mechanical hyperalgesia and cold allodynia compared with the SNI group. A microarray was applied to analyze differentially expressed of mRNA among different groups, and THP noticeably changed the expression of MAPK-related proteins compared with the SNI groups. H&E staining showed that the THP changed the inflammation after the spared nerve injury, with decreased NO expression in the THP group as compared to the SNI group. In addition, SNI-induced pain was reversed by intraperitoneal administration of THP, and further results indicated that THP suppressed inducible nitric oxide synthase (iNOS, pro-nociceptive mediators), phosphorylated MAPKs, and p65 in the dorsal root ganglions and sciatic nerve, while the serum levels of the pro-inflammatory cytokines IL-1β were significantly higher in the SNI group as compared to the THP group. To identify the molecular mechanism of the antineuropathic activity of THP, sodium nitroprusside (SNP)-induced neuro-2a (N2a) cells, LPS-induced BV2 cells, and LTA-induced astrocytes were further investigated in signaling pathways. In vitro experiments indicated that THP suppressed the expression of IL-1β, iNOS, phosphorylated MAPKs, and p65, which were assayed using western blotting, and immunofluorescence. Springer US 2021-11-10 2022 /pmc/articles/PMC8956562/ /pubmed/34757554 http://dx.doi.org/10.1007/s10753-021-01593-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Hu, Cheng
He, Menglin
Chen, Meijuan
Xu, Qian
Li, Sha
Cui, Yaomei
Qiu, Xizi
Tian, Weiqian
Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
title Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
title_full Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
title_fullStr Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
title_full_unstemmed Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
title_short Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
title_sort amelioration of neuropathic pain and attenuation of neuroinflammation responses by tetrahydropalmatine through the p38mapk/nf-κb/inos signaling pathways in animal and cellular models
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956562/
https://www.ncbi.nlm.nih.gov/pubmed/34757554
http://dx.doi.org/10.1007/s10753-021-01593-x
work_keys_str_mv AT hucheng ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT hemenglin ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT chenmeijuan ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT xuqian ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT lisha ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT cuiyaomei ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT qiuxizi ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels
AT tianweiqian ameliorationofneuropathicpainandattenuationofneuroinflammationresponsesbytetrahydropalmatinethroughthep38mapknfkbinossignalingpathwaysinanimalandcellularmodels